Results for tag: "Allergic Conjunctivitis"

Within the field of Allergy and Immunology, allergic conjunctivitis represents a common ocular condition characterized by the inflammation of the conjunctiva due to allergic reactions. It is typically triggered by allergens such as pollen, pet dander, or dust mites, resulting in symptoms including redness, itching, and tearing in the eyes. The market for allergic conjunctivitis treatments encompasses a variety of therapeutic options designed to mitigate these symptoms and improve the quality of life for affected individuals. These treatments range from over-the-counter antihistamines and decongestants to prescription medications such as anti-inflammatory drops and mast cell stabilizers. Immunotherapy is also a potential approach for long-term management, aiming at desensitizing the immune system to specific allergens. Several companies are active in the allergic conjunctivitis market. Some of these include Novartis, which offers prescription treatments for ocular allergies, and Allergan, known for its eye care products including medications for eye inflammation and redness. Alcon, as a division of Novartis, provides a portfolio of ophthalmology medications, including those for the treatment of symptoms related to allergic conjunctivitis. Additionally, Johnson & Johnson, through its acquisition of Actelion, has products that cater to various allergy-related conditions, including those affecting the eyes. Show Less Read more